4th Quarter - Termination

MEHLMAN CONSULTING, INC. for ASTRAZENECA PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2011

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

International trade issues, including free-trade agreements, import safety.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Budget issues, including Medicare Part D Rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage. Legislation to address physician payments issues, including SGR and related provisions to Medicare package. Independent Payment Advisory Board. Budget Control Act of 2011 (Became PL 112-25 on August 2, 2011), Implementation SEE CONTINUATION PAGE H.R. 3630, Temporary Payroll Tax Cut Contribution Act of 2011 H.R. 3765, Temporary Payroll Tax Cut Contribution Act of 2011 (Became PL 112-78 on 12-23-11)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3765 (112th), H.R. 3630 (112th)

Health Issues HCR

H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act. Prescription Drug User Fee Act (PDUFA) Budget Control Act of 2011 (Became PL 112-25 on 8-2-11), Implementation. H.R. 3630, Temporary Payroll Tax Cut Contribution Act of 2011 H.R. 3765, Temporary Payroll Tax Cut Contribution Act of 2011 (Became PL 112-78 on 12-23-11)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2182 (112th), H.R. 3630 (112th), H.R. 3765 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.